Virtual Pharmacist Service Nominated for the 2012 European SME eHealth Competition

The Swedish virtual pharmacist service has been nominated for the 2012 European SME eHealth Competition which honors the best innovations within eHealth in Europe. With the support of the ICT for Health Unit at the European Commission, the best eHealth solutions of 2012 produced by small and medium enterprises in EU will be rewarded. Among the finalists is the world's first virtual pharmacist.

The virtual pharmacist is a robot with artificial intelligence that has been trained in self-diagnosis and self-treatment. The Virtual Pharmacist helps Swedish people choose the right over-the-counter drug for more than a hundred common self-treatable everyday ailments such as hemorrhoids, rashes and more. The robot's knowledge is dynamically updated from the quality-assured database Medicinera.se and the number of questions that the virtual pharmacist can answer to is increasing every day. The service is available on the Web as well as smartphones applications. The virtual pharmacist and Medicinera.se has been developed by Scandinavian Outcomes AB.

About Scandinavian Outcomes AB
Scandinavian Outcomes AB is a consultancy company dedicated to improve medication use and treatment outcomes with projects and services designed for the needs of doctors, patients and consumers.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...